COVID-19 Impact on Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C80B14F52617EN
QYResearch

Abstracts

This report focuses on the global Substance Use Disorders (SUDs) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Substance Use Disorders (SUDs) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Indivior
• Pfizer
• Alkermes
• Novartis
• Mylan
• Cipla
• Glenmark
• Dr. Reddy's Laboratories
• Teva Pharmaceutical

Market segment by Type, the product can be split into

• Opioid Addiction
• Tobacco/Nicotine Addiction
• Alcohol Dependence

Market segment by Application, split into

• Hospital & Clinics
• Residential (non-hospital)

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Substance Use Disorders (SUDs) Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Substance Use Disorders (SUDs) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Substance Use Disorders (SUDs) Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Substance Use Disorders (SUDs) Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Substance Use Disorders (SUDs) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Opioid Addiction
  1.4.3 Tobacco/Nicotine Addiction
  1.4.4 Alcohol Dependence
1.5 Market by Application
  1.5.1 Global Substance Use Disorders (SUDs) Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital & Clinics
  1.5.3 Residential (non-hospital)
1.6 Coronavirus Disease 2019 (Covid-19): Substance Use Disorders (SUDs) Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Substance Use Disorders (SUDs) Treatment Industry
    1.6.1.1 Substance Use Disorders (SUDs) Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Substance Use Disorders (SUDs) Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Substance Use Disorders (SUDs) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Substance Use Disorders (SUDs) Treatment Market Perspective (2015-2026)
2.2 Substance Use Disorders (SUDs) Treatment Growth Trends by Regions
  2.2.1 Substance Use Disorders (SUDs) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Substance Use Disorders (SUDs) Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Substance Use Disorders (SUDs) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Substance Use Disorders (SUDs) Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Substance Use Disorders (SUDs) Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Substance Use Disorders (SUDs) Treatment Players by Market Size
  3.1.1 Global Top Substance Use Disorders (SUDs) Treatment Players by Revenue (2015-2020)
  3.1.2 Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Substance Use Disorders (SUDs) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Substance Use Disorders (SUDs) Treatment Market Concentration Ratio
  3.2.1 Global Substance Use Disorders (SUDs) Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Substance Use Disorders (SUDs) Treatment Revenue in 2019
3.3 Substance Use Disorders (SUDs) Treatment Key Players Head office and Area Served
3.4 Key Players Substance Use Disorders (SUDs) Treatment Product Solution and Service
3.5 Date of Enter into Substance Use Disorders (SUDs) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Substance Use Disorders (SUDs) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Substance Use Disorders (SUDs) Treatment Forecasted Market Size by Type (2021-2026)

5 SUBSTANCE USE DISORDERS (SUDS) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)
5.2 Global Substance Use Disorders (SUDs) Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
6.2 Substance Use Disorders (SUDs) Treatment Key Players in North America (2019-2020)
6.3 North America Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
6.4 North America Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
7.2 Substance Use Disorders (SUDs) Treatment Key Players in Europe (2019-2020)
7.3 Europe Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
7.4 Europe Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
8.2 Substance Use Disorders (SUDs) Treatment Key Players in China (2019-2020)
8.3 China Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
8.4 China Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
9.2 Substance Use Disorders (SUDs) Treatment Key Players in Japan (2019-2020)
9.3 Japan Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
9.4 Japan Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
10.2 Substance Use Disorders (SUDs) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
11.2 Substance Use Disorders (SUDs) Treatment Key Players in India (2019-2020)
11.3 India Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
11.4 India Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
12.2 Substance Use Disorders (SUDs) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Indivior
  13.1.1 Indivior Company Details
  13.1.2 Indivior Business Overview and Its Total Revenue
  13.1.3 Indivior Substance Use Disorders (SUDs) Treatment Introduction
  13.1.4 Indivior Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020))
  13.1.5 Indivior Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview and Its Total Revenue
  13.2.3 Pfizer Substance Use Disorders (SUDs) Treatment Introduction
  13.2.4 Pfizer Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 Alkermes
  13.3.1 Alkermes Company Details
  13.3.2 Alkermes Business Overview and Its Total Revenue
  13.3.3 Alkermes Substance Use Disorders (SUDs) Treatment Introduction
  13.3.4 Alkermes Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  13.3.5 Alkermes Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Substance Use Disorders (SUDs) Treatment Introduction
  13.4.4 Novartis Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Mylan
  13.5.1 Mylan Company Details
  13.5.2 Mylan Business Overview and Its Total Revenue
  13.5.3 Mylan Substance Use Disorders (SUDs) Treatment Introduction
  13.5.4 Mylan Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  13.5.5 Mylan Recent Development
13.6 Cipla
  13.6.1 Cipla Company Details
  13.6.2 Cipla Business Overview and Its Total Revenue
  13.6.3 Cipla Substance Use Disorders (SUDs) Treatment Introduction
  13.6.4 Cipla Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  13.6.5 Cipla Recent Development
13.7 Glenmark
  13.7.1 Glenmark Company Details
  13.7.2 Glenmark Business Overview and Its Total Revenue
  13.7.3 Glenmark Substance Use Disorders (SUDs) Treatment Introduction
  13.7.4 Glenmark Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  13.7.5 Glenmark Recent Development
13.8 Dr. Reddy's Laboratories
  13.8.1 Dr. Reddy's Laboratories Company Details
  13.8.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue
  13.8.3 Dr. Reddy's Laboratories Substance Use Disorders (SUDs) Treatment Introduction
  13.8.4 Dr. Reddy's Laboratories Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  13.8.5 Dr. Reddy's Laboratories Recent Development
13.9 Teva Pharmaceutical
  13.9.1 Teva Pharmaceutical Company Details
  13.9.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  13.9.3 Teva Pharmaceutical Substance Use Disorders (SUDs) Treatment Introduction
  13.9.4 Teva Pharmaceutical Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  13.9.5 Teva Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Substance Use Disorders (SUDs) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Substance Use Disorders (SUDs) Treatment Revenue
Table 3. Ranking of Global Top Substance Use Disorders (SUDs) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Substance Use Disorders (SUDs) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Opioid Addiction
Table 6. Key Players of Tobacco/Nicotine Addiction
Table 7. Key Players of Alcohol Dependence
Table 8. COVID-19 Impact Global Market: (Four Substance Use Disorders (SUDs) Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Substance Use Disorders (SUDs) Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Substance Use Disorders (SUDs) Treatment Players to Combat Covid-19 Impact
Table 13. Global Substance Use Disorders (SUDs) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Substance Use Disorders (SUDs) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Substance Use Disorders (SUDs) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Substance Use Disorders (SUDs) Treatment Market Share by Regions (2015-2020)
Table 17. Global Substance Use Disorders (SUDs) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Substance Use Disorders (SUDs) Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Substance Use Disorders (SUDs) Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Substance Use Disorders (SUDs) Treatment Players
Table 24. Global Substance Use Disorders (SUDs) Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Substance Use Disorders (SUDs) Treatment Market Share by Players (2015-2020)
Table 26. Global Top Substance Use Disorders (SUDs) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Substance Use Disorders (SUDs) Treatment as of 2019)
Table 27. Global Substance Use Disorders (SUDs) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Substance Use Disorders (SUDs) Treatment Product Solution and Service
Table 30. Date of Enter into Substance Use Disorders (SUDs) Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Substance Use Disorders (SUDs) Treatment Market Size Share by Type (2015-2020)
Table 34. Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Substance Use Disorders (SUDs) Treatment Market Size Share by Application (2015-2020)
Table 36. Global Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Substance Use Disorders (SUDs) Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Substance Use Disorders (SUDs) Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Substance Use Disorders (SUDs) Treatment Market Share (2019-2020)
Table 40. North America Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Substance Use Disorders (SUDs) Treatment Market Share by Type (2015-2020)
Table 42. North America Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Substance Use Disorders (SUDs) Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Substance Use Disorders (SUDs) Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Substance Use Disorders (SUDs) Treatment Market Share (2019-2020)
Table 46. Europe Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Substance Use Disorders (SUDs) Treatment Market Share by Type (2015-2020)
Table 48. Europe Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Substance Use Disorders (SUDs) Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Substance Use Disorders (SUDs) Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Substance Use Disorders (SUDs) Treatment Market Share (2019-2020)
Table 52. China Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Substance Use Disorders (SUDs) Treatment Market Share by Type (2015-2020)
Table 54. China Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Substance Use Disorders (SUDs) Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Substance Use Disorders (SUDs) Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Substance Use Disorders (SUDs) Treatment Market Share (2019-2020)
Table 58. Japan Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Substance Use Disorders (SUDs) Treatment Market Share by Type (2015-2020)
Table 60. Japan Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Substance Use Disorders (SUDs) Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Substance Use Disorders (SUDs) Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Substance Use Disorders (SUDs) Treatment Market Share (2019-2020)
Table 64. Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Substance Use Disorders (SUDs) Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Substance Use Disorders (SUDs) Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Substance Use Disorders (SUDs) Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Substance Use Disorders (SUDs) Treatment Market Share (2019-2020)
Table 70. India Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Substance Use Disorders (SUDs) Treatment Market Share by Type (2015-2020)
Table 72. India Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Substance Use Disorders (SUDs) Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Substance Use Disorders (SUDs) Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Substance Use Disorders (SUDs) Treatment Market Share (2019-2020)
Table 76. Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Substance Use Disorders (SUDs) Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Substance Use Disorders (SUDs) Treatment Market Share by Application (2015-2020)
Table 80. Indivior Company Details
Table 81. Indivior Business Overview
Table 82. Indivior Product
Table 83. Indivior Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 84. Indivior Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Alkermes Company Details
Table 91. Alkermes Business Overview
Table 92. Alkermes Product
Table 93. Alkermes Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 94. Alkermes Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Product
Table 103. Mylan Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 104. Mylan Recent Development
Table 105. Cipla Company Details
Table 106. Cipla Business Overview
Table 107. Cipla Product
Table 108. Cipla Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 109. Cipla Recent Development
Table 110. Glenmark Company Details
Table 111. Glenmark Business Overview
Table 112. Glenmark Product
Table 113. Glenmark Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 114. Glenmark Recent Development
Table 115. Dr. Reddy's Laboratories Business Overview
Table 116. Dr. Reddy's Laboratories Product
Table 117. Dr. Reddy's Laboratories Company Details
Table 118. Dr. Reddy's Laboratories Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 119. Dr. Reddy's Laboratories Recent Development
Table 120. Teva Pharmaceutical Company Details
Table 121. Teva Pharmaceutical Business Overview
Table 122. Teva Pharmaceutical Product
Table 123. Teva Pharmaceutical Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020) (Million US$)
Table 124. Teva Pharmaceutical Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Substance Use Disorders (SUDs) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Opioid Addiction Features
Figure 3. Tobacco/Nicotine Addiction Features
Figure 4. Alcohol Dependence Features
Figure 5. Global Substance Use Disorders (SUDs) Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital & Clinics Case Studies
Figure 7. Residential (non-hospital) Case Studies
Figure 8. Substance Use Disorders (SUDs) Treatment Report Years Considered
Figure 9. Global Substance Use Disorders (SUDs) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Substance Use Disorders (SUDs) Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Substance Use Disorders (SUDs) Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Substance Use Disorders (SUDs) Treatment Market Share by Players in 2019
Figure 14. Global Top Substance Use Disorders (SUDs) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Substance Use Disorders (SUDs) Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Substance Use Disorders (SUDs) Treatment Revenue in 2019
Figure 16. North America Substance Use Disorders (SUDs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Substance Use Disorders (SUDs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Substance Use Disorders (SUDs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Substance Use Disorders (SUDs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Substance Use Disorders (SUDs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Substance Use Disorders (SUDs) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Indivior Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Indivior Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 27. Alkermes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Alkermes Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 31. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Mylan Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 33. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Cipla Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 35. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Glenmark Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 37. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Dr. Reddy's Laboratories Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 39. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Teva Pharmaceutical Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed